Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
14 |
Employees |
30 |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-46 |
Cash Flow (TTM) (Millions $) |
-30 |
Capital Exp. (TTM) (Millions $) |
0 |
9 Meters Biopharma Inc
9 Meters Biopharma Inc is a clinical-stage biotechnology company that focuses on developing innovative therapies for patients with rare and orphan diseases. The company was founded in 2015 and is headquartered in Raleigh, North Carolina.
The primary goal of 9 Meters Biopharma Inc is to provide new and effective treatments for patients with rare diseases, many of whom have limited treatment options. The company is committed to developing therapies that can address the underlying cause of these diseases, rather than just treating symptoms.
One of the key areas of focus for 9 Meters Biopharma Inc is celiac disease, a condition in which the immune system attacks the small intestine when gluten is ingested. The company is developing a drug called Larazotide Acetate, which is a peptide that helps to prevent the immune system from attacking the small intestine. The drug is currently in Phase 3 clinical trials and has the potential to become the first FDA-approved treatment for celiac disease.
9 Meters Biopharma Inc is also developing a drug called NM-002, which is designed to treat a rare genetic disorder called NASH (non-alcoholic steatohepatitis). NASH is a condition in which fat builds up in the liver and can cause inflammation, scarring, and liver damage. NM-002 is currently in preclinical development and has shown promise in animal studies.
In addition to its work in celiac disease and NASH, 9 Meters Biopharma Inc is exploring potential treatments for other rare and orphan diseases. The company has a pipeline of drug candidates, including several that are in preclinical development.
Overall, 9 Meters Biopharma Inc is a promising biotech company that is dedicated to developing innovative therapies for patients with rare and orphan diseases. Its focus on addressing the underlying causes of these conditions sets it apart from other companies in the industry, and its commitment to patient care and advocacy is evident in its mission and values. With several promising drug candidates in its portfolio, 9 Meters Biopharma Inc has the potential to make a significant impact on the lives of patients with rare diseases.
Company Address: 4509 Creedmoor Road Raleigh 27612 NC
Company Phone Number: 275-1933 Stock Exchange / Ticker: NASDAQ NMTR
|